Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alpha in Myelodysplastic Syndromes
NCT00443339Phase 2Unknown
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Dec 2006
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in myelodysplastic syndrome (MDS), sponsored by Groupe Français des Myélodysplasies. Status: unknown.
02
Drugs
darbepoetin alfa
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00443339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443339.